TORONTO, June 6, 2019 /PRNewswire/ – SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE:SOL) (Frankfurt:9SB) (OTCQB: SOLCF) announces that it has acquired an aggregate of 4,831,500 common shares and 2,349,500 common share purchase warrants of Frankly Inc. (“Frankly”) (TSX-V:TLK), representing 16.3% of the issued and outstanding common shares of Frankly on a non-diluted basis and 22.5% of Frankly on a partially diluted basis. SOL Global acquired an initial aggregate position of 4,700,000 common shares and the 2,349,500 common share purchase warrants between May 10, 2019 and May 22, 2019 pursuant to a private placement offering of Frankly units at a price of $0.35 per unit for an aggregate purchase price of $1,645,000 (the “Frankly Private Placement”). Each unit was comprised of one (1) common share of Frankly and one-half (1/2) of one warrant with each whole warrant exercisable for one common share of Frankly at an exercise price of $0.65 for a period of 24 months from the issue date. SOL Global did not hold any securities of Frankly prior to the Frankly Private Placement.

TORONTO, June 6, 2019 /PRNewswire/ – Beleave Inc. (“Beleave” or the “Company”) (CSE: BE; OTCQX: BLEVF) today announces a settlement with the British Columbia Securities Commission (“BCSC”), and provides updates to certain prior disclosure regarding agreements entered into and shares issued by the Company during its fiscal year ended March 31, 2019. All values in this news release are in Canadian dollars.

– Ziva Cooper, Ph.D. and Mallory Loflin, Ph.D. become latest members of the renowned group of FSD Scientific Advisors led by Charles Pollack, Jr. MD, FACEP

CHATHAM, ON, June 6, 2019 /CNW/ – AgMedica Bioscience Inc. (“AgMedica” or the “Company”), a licensed producer of cannabis for medicinal and adult-use consumers, is pleased to announce that it has received approval from Health Canada for a license amendment allowing for the sale of cannabis oil products, effective May 31, 2019. The cannabis oil sales license enables AgMedica to provide medicinal patients and adult-use consumers with greater choice through a portfolio of bottled oils that includes CBD, THC and Balanced varieties, all of which are considered higher-demand products.

NEW YORK, June 6, 2019 /PRNewswire/ — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Plus Products Inc. (CSE: PLUS; OTCQX: PLPRF), a leading cannabis branded products company in the U.S., has qualified to trade on the OTCQX® Best Market. Plus Products upgraded to OTCQX from the OTCQB® Venture Market.